Detalhe da pesquisa
1.
Broad white matter impairment in multiple system atrophy.
Hum Brain Mapp
; 42(2): 357-366, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064319
2.
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.
Mov Disord
; 35(11): 1957-1965, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882100
3.
Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.
J Neural Transm (Vienna)
; 126(6): 789-793, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31098725
4.
MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.
Mov Disord
; 33(4): 600-608, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473662
5.
Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp.
Diabetes Obes Metab
; 20(1): 157-164, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28681996
6.
The Unified Multiple System Atrophy Rating Scale: intrarater reliability.
Mov Disord
; 27(13): 1683-5, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23114993
7.
Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
Mov Disord
; 26(1): 153-7, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20960436
8.
Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study.
Mov Disord
; 25(3): 368-76, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20063435
9.
Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry.
Mov Disord
; 25(15): 2604-12, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20922810
10.
Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
Parkinsonism Relat Disord
; 65: 146-152, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182373
11.
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial.
Parkinsonism Relat Disord
; 60: 51-56, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297210
12.
Parkinson's patients can rely on perspective cues to perceive 3D space.
Brain Res
; 1663: 161-165, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28327351
13.
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
Neurology
; 82(4): 300-7, 2014 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371304
14.
Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.
Parkinsonism Relat Disord
; 19(4): 416-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23283428
15.
A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson's disease.
Fundam Clin Pharmacol
; 26(4): 557-64, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21585523
16.
Usefulness of OSLER test in Parkinson's disease.
Sleep Med
; 14(3): 297-8, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23072815
17.
Clinical and economic analysis of spa therapy in Parkinson's disease.
Mov Disord
; 18(5): 578-84, 2003 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12722173
18.
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Mov Disord
; 19(12): 1391-402, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15452868